186 related articles for article (PubMed ID: 36422738)
1. Initial clinical and experimental analyses of ALDOA in gastric cancer, as a novel prognostic biomarker and potential therapeutic target.
Chen L; Wu Z; Guo J; Wang X; Zhao Z; Liang H; Zhang R; Deng J
Clin Exp Med; 2023 Oct; 23(6):2443-2456. PubMed ID: 36422738
[TBL] [Abstract][Full Text] [Related]
2. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.
Jiang Z; Wang X; Li J; Yang H; Lin X
J Cell Mol Med; 2018 Sep; 22(9):4377-4386. PubMed ID: 29992789
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of the role of aldolase A in tumor prognosis and immunity.
Tian W; Zhou J; Chen M; Qiu L; Li Y; Zhang W; Guo R; Lei N; Chang L
Sci Rep; 2022 Jul; 12(1):11632. PubMed ID: 35804089
[TBL] [Abstract][Full Text] [Related]
4. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
Kawai K; Uemura M; Munakata K; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2017 Feb; 50(2):525-534. PubMed ID: 28000858
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA PSMA3-AS1 functions as a competing endogenous RNA to promote gastric cancer progression by regulating the miR-329-3p/ALDOA axis.
Kan L; Yang M; Zhang H
Biol Direct; 2023 Jul; 18(1):36. PubMed ID: 37403106
[TBL] [Abstract][Full Text] [Related]
6. The role of fructose 1,6-bisphosphate-mediated glycolysis/gluconeogenesis genes in cancer prognosis.
Li CH; Chan MH; Chang YC
Aging (Albany NY); 2022 Apr; 14(7):3233-3258. PubMed ID: 35404841
[TBL] [Abstract][Full Text] [Related]
7. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
[TBL] [Abstract][Full Text] [Related]
8. Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma.
Saito Y; Takasawa A; Takasawa K; Aoyama T; Akimoto T; Ota M; Magara K; Murata M; Hirohashi Y; Hasegawa T; Sawada N; Saito T; Osanai M
Cancer Sci; 2020 Aug; 111(8):3071-3081. PubMed ID: 32530543
[TBL] [Abstract][Full Text] [Related]
9. Fructose-Bisphosphate Aldolase A Regulates Hypoxic Adaptation in Hepatocellular Carcinoma and Involved with Tumor Malignancy.
Li X; Jiang F; Ge Z; Chen B; Yu J; Xin M; Wang J; An L; Wei J; Wu L
Dig Dis Sci; 2019 Nov; 64(11):3215-3227. PubMed ID: 31041640
[TBL] [Abstract][Full Text] [Related]
10. ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.
Ji S; Zhang B; Liu J; Qin Y; Liang C; Shi S; Jin K; Liang D; Xu W; Xu H; Wang W; Wu C; Liu L; Liu C; Xu J; Ni Q; Yu X
Cancer Lett; 2016 Apr; 374(1):127-135. PubMed ID: 26854714
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma.
Lu G; Shi W; Zhang Y
Front Genet; 2021; 12():721021. PubMed ID: 34925439
[No Abstract] [Full Text] [Related]
12. Aldolase A promotes cell proliferation and cisplatin resistance via the EGFR pathway in gastric cancer.
Gu M; Jiang B; Li H; Zhu D; Jiang Y; Xu W
Am J Transl Res; 2022; 14(9):6586-6595. PubMed ID: 36247245
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
[TBL] [Abstract][Full Text] [Related]
14. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
15. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
16. MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis.
Wang J; Zhang HM; Dai ZT; Huang Y; Liu H; Chen Z; Wu Y; Liao XH
Sci Rep; 2022 Dec; 12(1):21283. PubMed ID: 36494481
[TBL] [Abstract][Full Text] [Related]
17. Role of aldolase A in osteosarcoma progression and metastasis: in vitro and in vivo evidence.
Long F; Cai X; Luo W; Chen L; Li K
Oncol Rep; 2014 Nov; 32(5):2031-7. PubMed ID: 25215901
[TBL] [Abstract][Full Text] [Related]
18. High expression of aldolase A is associated with tumor progression and poor prognosis in hepatocellular carcinoma.
Tang Y; Yang X; Feng K; Hu C; Li S
J Gastrointest Oncol; 2021 Feb; 12(1):174-183. PubMed ID: 33708434
[TBL] [Abstract][Full Text] [Related]
19. Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness.
Chang YC; Yang YF; Chiou J; Tsai HF; Fang CY; Yang CJ; Chen CL; Hsiao M
Cell Death Dis; 2020 Mar; 11(3):195. PubMed ID: 32188842
[TBL] [Abstract][Full Text] [Related]
20. Prognosis significance and potential association between ALDOA and AKT expression in colorectal cancer.
Xu M; Xi S; Li H; Xia Y; Mei G; Cheng Z
Sci Rep; 2024 Mar; 14(1):6488. PubMed ID: 38499636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
